Allan Böhm

Better late than never. Here’s our 2025 Seerlinq wrap-up 🚀 If you told me a year ago we’d achieve all this in 12 months, I’d say: no chance. But 2025 turned out to be a breakthrough year. What we delivered 👇 • CE-marked MDR Class IIb – world’s first non-invasive remote cardiac filling pressure monitoring • Top innovation @ THT Boston • Reimbursed by all Slovak insurers + full reimbursement in Germany • ESC HF Late-Breaker • JACC publication • 4× presentations at ESC Congress Madrid • Strategic partnership with Samsung (HF smartwatch diagnostics) • €4M R&D grant secured • 600+ HF patients monitored • First study: >50% reduction in HF hospitalizations & deaths This is proof that scalable, non-invasive haemodynamic monitoring can move from vision to real-world care - and keep patients out of hospital. Huge thanks to clinicians, patients, partners, insurers, regulators, and our team. 2026 - we’re coming. #HeartFailure #DigitalHealth #MedTech #AIinHealthcare #Cardiology #Seerlinq @rafavidalperez @_antocannata @PragueICU @HanCardiomd @ANazmiCalik

I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.

Great to be at #HeartFailure26 in Barcelona with the @Seerlinq team! 🫀 Heart failure still sends too many patients to hospital too late. We’re changing that with non-invasive, AI-powered remote hemodynamic monitoring using only PPG signals — detecting deterioration weeks in advance. MDR Class IIb certified ✔️ Reimbursed in multiple countries ✔️ Hundreds of patients already monitored in routine practice ✔️ The future of heart failure care is proactive, personalized & remote. Excited for the conversations this week! @ARakisheva @_antocannata @drbennisahmed @GianluSava

🫀 #HFA2026 | Barcelona, May 9–12 — Most Anticipated Trials #HeartFailure26 7 late-breaking sessions, a record number of submissions, and groundbreaking data expected. Here’s what to watch 👇 🔥 Hottest Trials (1) — May 9 ▸ #SUBCUTHFII — Subcutaneous furosemide for early discharge post-HF admission ▸ #REDOXAHF — Restrictive vs. liberal O₂ targets in acute HF ▸ #RePHIRE — AZD3427 (relaxin mimetic) in HF + pulmonary hypertension ▸ #PRAISEMR — Sacubitril-valsartan in HFpEF + secondary mitral regurgitation ▸ #CONDUCTAF — Conduction system vs. biventricular pacing post-AV node ablation 🔬 Innovations in HF Management — May 9 ▸ #UFCARE — Ultrafiltration in cardiorenal syndrome type 2 ▸ #TRANSFORMHF — Diuretic resistance strategies ▸ #TIMHF3 — Voice-based AI prediction of HF hospitalization ▸ #CARDIOTTRansform — New trial in ATTR-CM 💊 Advances in Cardiomyopathies — May 11 ▸ #RESOLVEHCM — Perhexiline in hypertrophic cardiomyopathy ▸ #MAPLEHCM — Dose-dependent effects in HCM ▸ #ATTRibuteCM — Outpatient worsening HF in ATTR-CM ▸ #BHB/HRS1893 — Non-obstructive HCM 🌍 Global Insights — May 11 ▸ #THESUSHFII — Acute HF in Africa ▸ #NEDA — Treatment trends & outcomes from Australia The theme says it all: “Evolution in Heart Failure” 🚀 #HeartFailure2026 #ESCHeartFailure #HFA #Cardiology #CardioTwitter #LateBreakingScience #HFpEF #ATTRCM #HCM #AcuteHeartFailure

Here we go #HRS2026 On the highly touted AVANT GAURD RCT of Boston scientific Farapulse PFA vs AAD. nejm.org/doi/full/10.10… The Topline results are positive. Look at that KM curve But let's look under the hood so as not to be bamboozled A thread coming and it's quite surprising

@Jorgeheartshock @Cardiologia_Mx @franciscojlk @lucabaldetti @guglielmogallo1 @BocchinoPier @alexariasmx20 @inc80aniv @smexcardiologia Congrats 👏

PAC is not dead.🫀⚡ 2nd place Runner-Up #YIA #ACVC2026 for our meta-Analysis on pulmonary artery catheter in cardiogenic shock. Time to rethink hemodynamics. Proud research from @Cardiologia_Mx And international collaboration #CardioTwitter #CardiogenicShock

Looking for the updates👍

At #LSIUSA26 in Los Angeles this week. Excited to connect with innovators, clinicians, and investors shaping the future of med-tech. At Seerlinq we are working to democratize precision cardiovascular care by transforming PPG into a clinically actionable signal - enabling non-invasive remote monitoring of cardiac filling pressures in heart failure. Happy to connect! @lsintelligence

Huge

That’s a wrap on #THT2026! 🎉 A huge thank you to everyone who joined us. Here’s to another year of discoveries, breakthroughs, and connections. 🙌 Together we’re advancing science and improving outcomes for people living with #heartfailure around the world. See you next year! 🌐🫀 #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @HFSA @asaiojournal @ISHLT @JCardFail @SophiaAirhartMD @michel_helou @RohangantiMD @igor_igorgosev @AHajduczok @DHayesMD @Ibrahim_Kamel9 @dor_lotan @DavidMajureMD @Nikhil15 @SomPSingh

#THT2026 is officially underway! Exciting sessions, new connections, and ideas shaping the next era of #HeartFailure care. 💡🫀 #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @HFSA @asaiojournal @ISHLT @JCardFail @SophiaAirhartMD @michel_helou @RohangantiMD @igor_igorgosev @AHajduczok @DHayesMD @Ibrahim_Kamel9 @dor_lotan @DavidMajureMD @Nikhil15 @SomPSingh

Join us for the late-breaking science presentation at THT 2026 to see the full data. #THT2026 Next milestone: randomized trial of pre-emptive percutaneous MCS in high-risk patients identified by the #STOPSHOCK score — to prevent cardiogenic shock altogether. See you at the session @crfheart ! Let’s #STOPSHOCK together! 🤝🏥🫀 #Cardiology #CardiogenicShock #ClinicalTrials #PrecisionMedicine #ACS #MCS @rafavidalperez @PragueICU @krychtiukmd @Jorgeheartshock @AmitaiSegev1 @drmilicaa

For real-world robustness, we prospectively validated it in >1,000 patients across 10 geographically diverse tertiary centres. Results confirmed consistent, excellent performance in today’s heterogeneous ACS population. 🌍 Excited to share: the final results are in!

Cardiogenic shock remains one of the most feared complications of acute coronary syndrome still hitting ~10% of patients with a~50% mortality rate. Even modern mechanical support often arrives too late. The therapeutic window is razor-thin…sometimes it feels like we’re chasing a moving train. 🚆

Still time to register for the #ACVC2026 congress @escardio Lisbon is waiting for you #ACVC_ESC #AcuteCV escardio.org/events/congres…

#THT2026 is almost here! 🫀 Make the most of your time at the premier destination for #heartfailure innovation with the Program Guide! 👉 ow.ly/pxWI50Ynhox #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @HFSA @asaiojournal @ISHLT @JCardFail @SophiaAirhartMD @michel_helou @RohangantiMD @igor_igorgosev @AHajduczok @DHayesMD @Ibrahim_Kamel9 @dor_lotan @DavidMajureMD @Nikhil15 @SomPSingh

Dive into the excitement of the THT Shark Tank Innovation Competition! 🦈 7 bold innovators will pitch cutting-edge novel technologies in #heartfailure and vie for $25,000 worth of services from MCRA. Get a glimpse of the groundbreaking discoveries in store at #THT2026 today! 👉 ow.ly/ilvR50Yipj7 #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @HFSA @asaiojournal @ISHLT @SophiaAirhartMD @igor_igorgosev @AHajduczok @Ibrahim_Kamel9 @dor_lotan @DavidMajureMD @Nikhil15 @SomPSingh

Momentum continues for Seerlinq🫀🚀 Our prospective study showing >50% reduction in HF hospitalizations & mortality with a non-invasive hemodynamic-guided strategy has been selected as a Late-Breaker - First-in-Man at CRF #THT2026, Boston. thtmeeting.com/program-guide

Make the most of your #THT2026 experience with can’t miss program highlights! ✨ Dive into the cutting-edge science, technology, and data shaping the future of #heartfailure treatment. 🫀 Start planning your journey with the Program Guide 👉 ow.ly/CUNw50YhRKO Not registered yet? There’s still time to secure your spot! ⌛ ow.ly/oSXR50YhRKK #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @HFSA @asaiojournal @ISHLT @Nikhil15 @dor_lotan @DavidMajureMD @igor_igorgosev @AHajduczok @SophiaAirhartMD